The proportion of individuals with monogenic diabetes who receive insulin before their monogenic diabetes diagnosis—the larger the proportion receiving insulin before being diagnosed as having monogenic diabetes, the greater the costs saved for all strategies compared with No Testing. This evidence concerns the gene INS and diabetes mellitus.